Special Situations Life Sciences Innovation Fund
5
25M
4
3
0.20
- Stages of investment
- Areas of investment
Summary
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Special Situations Life Sciences Innovation Fund, startups are often financed by Grand Central Tech. The meaningful sponsors for the fund in investment in the same round are Company Ventures.
Among the most popular portfolio startups of the fund, we may highlight TMRW Life Sciences. Among the most popular fund investment industries, there are Consumer, Biotechnology. Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund.
The important activity for fund was in 2019. Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is constantly included in 2-6 investment rounds annually.
Investments analytics
Analytics
- Total investments
- 5
- Lead investments
- 3
- Follow on index
- 0.20
- Investments by industry
- Health Care (5)
- Biotechnology (3)
- Life Science (2)
- Consumer (1)
- Consumer Goods (1) Show 8 more
- Investments by region
-
- United States (5)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Group Appearance index
- 0.80
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| TMRW Life Sciences | 20 Jul 2021 | Biotechnology, Health Care, Life Science | Late Stage Venture | 105M | United States, New York, New York |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.